FACTS ABOUT MUSCULAR DYSTROPHY TREATMENT REVEALED

lately, the antibiotic gentamicin is tested in boys with DMD, about ten% of whom have inherited a dystrophin gene that has a untimely end codon that halts the synthesis of the protein N-terminal into the dystroglycan binding region. Gentamicin suppresses chain termination, permitting some whole-duration dystrophin to become developed. This ends in